Cite
miR-125a-5p reverses epithelial-mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer.
MLA
Li, Dongmei, et al. “MiR-125a-5p Reverses Epithelial-Mesenchymal Transition and Restores Drug Sensitivity by Negatively Regulating TAFAZZIN Signaling in Breast Cancer.” Molecular Medicine Reports, vol. 24, no. 5, Nov. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.3892/mmr.2021.12452.
APA
Li, D., Chen, L., Zhang, X., Wang, Y., Huang, C., Li, J., He, F., & He, W. (2021). miR-125a-5p reverses epithelial-mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer. Molecular Medicine Reports, 24(5), N.PAG. https://doi.org/10.3892/mmr.2021.12452
Chicago
Li, Dongmei, Limei Chen, Xiaofang Zhang, Yanhua Wang, Chuansheng Huang, Jianglong Li, Feilong He, and Wenxing He. 2021. “MiR-125a-5p Reverses Epithelial-Mesenchymal Transition and Restores Drug Sensitivity by Negatively Regulating TAFAZZIN Signaling in Breast Cancer.” Molecular Medicine Reports 24 (5): N.PAG. doi:10.3892/mmr.2021.12452.